Kohlberg Kravis Roberts & Co »

Novocure shares owned by Kohlberg Kravis Roberts & Co

Quarter-by-quarter ownership of Novocure shares owned by Kohlberg Kravis Roberts & Co from 13F filings

Historical chart of Kohlberg Kravis Roberts & Co investment in Novocure

Tip: Access up to 7 years of quarterly data

All positions including Novocure held by Kohlberg Kravis Roberts & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novocure by Kohlberg Kravis Roberts & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 3.0M 0.87
2023-09-30 $2.6M 3.0M 0.87
2023-06-30 $412k 473k 0.87

More positions owned by Kohlberg Kravis Roberts & Co

Bridgebio Pharma (BBIO)
Brightview Holdings (BV)
Fs Kkr Capital Corp (FSK)
Applovin Corp Com Cl A (APP)
Propertyguru Group Ord Shs (PGRU)
Kkr Real Estate Finance Trust (KREF)
Endeavor Group Hldgs Cl A Com (EDR)
Ncl Corp Note 1.125% 2/1 (Principal)
Transphorm (TGAN)
Doordash Cl A (DASH)
Jetblue Airways Corp Note 0.500% 4/0 (Principal)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Marriott Vacations Worldwide Note 1/1 (Principal)
Redfin Corp Note 10/1 (Principal)
Realogy Grp Llc/realogy Note 0.250% 6/1 (Principal)

View all positions for Kohlberg Kravis Roberts & Co

Top funds holding Novocure

Braidwell
Tenor Capital Management
DeepCurrents Investment Group
Steelhead Partners
Balyasny Asset Management
Point72 Asset Management
Capstone Investment Advisors
Shenkman Capital Management
Jpmorgan Chase & Co
Kohlberg Kravis Roberts & Co
Bnp Paribas Investment Partners
Wells Fargo & Company
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Palisade Capital Management
Zazove Associates

View all funds holding Novocure